MICHAEL RUBALSKY: Open Payments
NPI 1407473697 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,505 in 72 payments from 17 companies in 2025. Trend: 2023 $1,212 · 2024 $802 · 2025 $1,505
Food & beverage: $1,505
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $262 |
| AstraZeneca Pharmaceuticals LP | 9 | $245 |
| Novo Nordisk Inc | 9 | $192 |
| ABBVIE INC. | 9 | $184 |
| GlaxoSmithKline, LLC. | 8 | $142 |
| PFIZER INC. | 4 | $94 |
| Lundbeck LLC | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Exact Sciences Corporation | 3 | $61 |
| Ardelyx, Inc. | 2 | $48 |
Products named: BREZTRI, VRAYLAR, REXULTI, MOUNJARO, JARDIANCE, Wegovy, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across CT — which companies pay providers there.
